|
|
Structure |
Product Information |
|
NOR004
Norvaline, N-[(1,1-dimethylethoxy)carbonyl]- [521286-38-4] |
|
ORM001
ormamide, N-(1H-benzotriazol-1-ylmethyl)- [87022-36-4] |
|
OXA001
2-Oxazolecarboxylic acid, 5-methyl-, ethyl ester [33123-68-1] |
|
OXA002
Oxazole, 5-ethoxy-2-propyl- [90087-72-2] |
|
OXA006
6-Oxabicyclo[3.2.1]octane-2-carboxylic acid, 7-oxo-, (1S,2S,5S)- [851000-67-4] |
|
OXA007
6-Oxabicyclo[3.2.1]octane-2-carboxylic acid, 7-oxo-, (1R,2S,5R)-rel- [2743-93-3] |
|
OXA008
6-Oxabicyclo[3.2.1]octane-2-carboxylic acid, 7-oxo-, methyl ester, (1S,2S,5R)-
|
|
OXA013
2-Oxazolidinone, 4-[[3-[2-(dimethylamino)ethyl]-1H-indol-5-yl]methyl]-, (4R)- [139264-17-8] |
|
OXA014
2-Oxazolidinone, 5-(azidomethyl)-3-[3-fluoro-4-(4-morpholinyl)phenyl]-, (5R)- [168828-84-0] |
|
OXA015
2-Oxazolidinecarboxylic acid, 4-phenyl-2-(trifluoromethyl)-, ethyl ester, (4R)- [1094092-25-7] |
|
OXA016
6-Oxabicyclo[3.2.1]octane-2-carboxylic acid, 7-oxo-, methyl ester, (1S,2R,5R)-
|
|
OXA018
4-Oxa-1-azabicyclo[4.2.0]octan-5-one, 7-(iodomethyl)-2-phenyl-6-(trifluoromethyl)-, (2S)-
|
|
OXA021
6-Oxa-2-azabicyclo[3.2.1]octan-7-one, (1S,5R)-
|
|
OXA022
6-Oxabicyclo[3.2.1]octane-2-carboxylic acid, 7-oxo-, (1R,2S,5S)-
|
|
OXA025
6-Oxabicyclo[3.2.1]octane-2-carboxylic acid, 4-iodo-7-oxo-, methyl ester, (1S,2S,5R)-
|
|
OXA026
6-Oxabicyclo[3.2.1]octane-2-carboxylic acid, 7-oxo-, methyl ester, (1S,2S,5S)-
|
|
OXA030
Oxazolidin-2-one,4-propyl-5-cyclopropylcarboxamino-
|
|
OXA031
2-Oxazolidinone, 3-[(3S)-1-oxo-3-[3-(phenylmethoxy)phenyl]pentyl]-4-phenyl-, (4R)- [1383959-13-4] |
|
OXA032
2-Oxazolidinone, 3-[(2S,3R)-2-methyl-1-oxo-3-[3-(phenylmethoxy)phenyl]pentyl]-4-phenyl-, (4R)- [1383959-15-6] |
|
OXA033
2-Oxazolidinone, 3-((2R,3S)-2-methyl3-ethyl-3-((3-benzyloxy)phenyl)-1-oxo-propyl)-,4-phenyl-, (4R)-
|
Products protected by valid patents are not offered for sale in countries where the sale of such products constitutes patent infringement and its liability is at buyer's risk. |
|
New products
|